Casandra
Casandra Test Code LC53456Version 1 (DRAFT)
Performing Lab
Methylphenidate and metabolite, urine
Clinical Use
Order TestUse
Detect use of methylphenidate, a prescription stimulant drug.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.
Test Details
Methodology
Mass Spectrometry
Biomarkers
Methylphenidate
AnalyteMethylphenidate • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Ritalinic acid
AnalyteRitalinic acid • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
10 mL
Minimum Volume
1 mL
Container
Plastic urine container or transport tube without preservative
Storage Instructions
Freeze immediately; ship frozen.
Causes for Rejection
Sample received in preservative tubes
Related Tests
Other tests from different labs that may be relevant
Methylphenidate and Metabolite, Urine, Quantitative
ARUP Laboratories
Methylphenidate and Metabolite, Random, Urine
Mayo Clinic Lab
Drug Monitoring, Methylphenidate Metabolite, Quantitative, Urine
Quest Diagnostics
Targeted Stimulant Screen, Random, Urine
Mayo Clinic Lab
Amphetamine Confirmation, Urine
Quest Diagnostics
Mephedrone, MDPV and Methylone, Urine
Mayo Clinic Lab
MDMA/MDA, Quantitative, Urine
Quest Diagnostics
Amphetamines Confirmation, Random, Urine
Mayo Clinic Lab
MDMA/MDA Screen, with Confirmation, Urine
Quest Diagnostics
MDMA/MDA
Quest Diagnostics